Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $54.29M | $33.68M | +61.18% |
Cost of Revenue | $32.44M | $32.71M | -0.80% |
Operating Income | $-295.24M | $-251.13M | -17.56% |
Net Income | $-284.75M | $-235.07M | -21.14% |
EPS (Basic) | $-1.12 | $-1.16 | +3.45% |
EPS (Diluted) | $-1.12 | $-1.16 | +3.45% |
R&D Expense | $216.09M | $171.74M | +25.82% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $726.5M | $630.83M | +15.17% |
Current Assets | $474.17M | $410.52M | +15.50% |
Total Liabilities | $201.94M | $192.86M | +4.71% |
Current Liabilities | $108.89M | $94.12M | +15.69% |
Stockholders' Equity | $524.56M | $437.97M | +19.77% |
Cash & Equivalents | $427.65M | $387.32M | +10.41% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-243.74M | $-213.7M | -14.06% |
Investing Cash Flow | $-15.4M | $-7.74M | -98.93% |
Financing Cash Flow | $293.48M | $59.47M | +393.46% |
D&A | $23.54M | $16.85M | +39.73% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -543.8% | -745.5% | +201.76% |
Net Margin | -524.5% | — | — |
ROE | -54.3% | — | — |
ROA | -39.2% | — | — |
Current Ratio | $4.355 | — | — |
Debt to Equity | $0.385 | — | — |
Other companies in Biotechnology